Intermolecular Board of Directors Authorizes $10 Million Share Repurchase Program
SAN JOSE, Calif., Nov. 6, 2018 /PRNewswire/ -- The board of directors of Intermolecular, Inc. (Nasdaq: IMI), the trusted partner for advanced materials innovation, has approved a share repurchase program pursuant to which Intermolecular may repurchase up to $10 million of shares of its common stock.
Under the share repurchase program, effective immediately, repurchases may be made from time-to-time, in amounts, at prices, and at such times as the company deems appropriate, subject to market conditions and federal and state laws governing such transactions. Intermolecular currently has approximately 49.8 million shares outstanding.
"Intermolecular is committed to continue executing on its strategic, operating and financial plans to maximize shareholder value," said Intermolecular CEO Chris Kramer. "We are well-capitalized with more than $30 million of cash and no debt, and we believe this share repurchase program is in the best interest of the company and our shareholders."
This program does not obligate Intermolecular to acquire any particular amount of common stock and the program may be suspended or discontinued at any time. Intermolecular expects to finance the purchases with existing cash balances.
About Intermolecular, Inc.
Intermolecular® is the trusted partner for advanced materials innovation. Advanced materials are at the core of innovation in the 21st century for a wide range of industries including semiconductors, consumer electronics, automotive and aerospace. With its substantial materials expertise, accelerated learning and experimentation platform, and information and analytics infrastructure, Intermolecular has a ten-year track record helping leading companies accelerate and de-risk materials innovation. Learn more at www.intermolecular.com.
"Intermolecular" and the Intermolecular logo are registered trademarks; all rights reserved.
Corporate Contact:
Bill Roeschlein
Intermolecular, Inc.
Chief Financial Officer
[email protected]
(408) 582-5415
Investor Contact:
Matt Glover or Najim Mostamand, CFA
Liolios
[email protected]
(949) 574-3860
SOURCE Intermolecular, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article